Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ADRIENNE D BRIGGS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1821065830
CMS profile
354613
Location
SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$754.54

31 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $754.54 31

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–31 of 31 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ADRIENNE D BRIGGS

NPI 1821065830 · CMS profile ID 354613

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–31 of 31 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821065830?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ADRIENNE D BRIGGS, NPI 1821065830, CMS profile ID 354613. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–31 of 31 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821065830?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ADRIENNE D BRIGGS, NPI 1821065830, CMS profile ID 354613. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–31 of 31 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821065830?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ADRIENNE D BRIGGS, NPI 1821065830, CMS profile ID 354613, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–31 of 31 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1821065830?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

31 matching records · $754.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 31 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–31 of 31.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SERVIER PHARMACEUTICALS LLC $18.8412/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147257756 CMS
ABBVIE INC. $22.4711/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103368313 CMS
PFIZER INC. $24.0511/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131072182 CMS
Amgen Inc. $19.7410/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111536419 CMS
Novartis Pharmaceuticals Corporation $15.7710/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086687905 CMS
Astellas Pharma US Inc $23.0910/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139404229 CMS
SANOFI-AVENTIS U.S. LLC $25.3909/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139922929 CMS
JAZZ PHARMACEUTICALS INC. $21.6609/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150233812 CMS
Merck Sharp & Dohme LLC $21.6109/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141748309 CMS
Daiichi Sankyo Inc. $25.0309/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089403108 CMS
SERVIER PHARMACEUTICALS LLC $20.9209/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147257754 CMS
Kite Pharma, Inc. $29.6608/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128613903 CMS
Kite Pharma, Inc. $18.5508/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128613905 CMS
JAZZ PHARMACEUTICALS INC. $23.6908/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150233814 CMS
Rigel Pharmaceuticals, Inc. $29.5907/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145204960 CMS
Genmab U.S., Inc. $34.4607/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126823764 CMS
JAZZ PHARMACEUTICALS INC. $26.0106/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150233810 CMS
SERVIER PHARMACEUTICALS LLC $22.5906/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147257752 CMS
Novartis Pharmaceuticals Corporation $21.0005/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086687899 CMS
Astellas Pharma US Inc $32.4805/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139332932 CMS
Daiichi Sankyo Inc. $29.4305/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089403106 CMS
JAZZ PHARMACEUTICALS INC. $30.8004/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150233808 CMS
Kite Pharma, Inc. $26.9004/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128613901 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.2304/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144954285 CMS
Celgene Corporation $24.8504/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101093231 CMS
ABBVIE INC. $26.7303/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103368311 CMS
Genmab U.S., Inc. $32.9003/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126823762 CMS
PFIZER INC. $20.8603/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131298269 CMS
Novartis Pharmaceuticals Corporation $23.4201/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086687891 CMS
PFIZER INC. $24.2801/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131292517 CMS
Kite Pharma, Inc. $20.5401/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128613899 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,782.92 34
PY2020 $106.27 5
PY2021 $1,142.95 3
PY2022 $1,376.87 25
PY2023 $1,287.94 38
PY2024 $754.54 31
PY2025 $1,039.25 34

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $111,099.82 7
PY2024 Principal investigator $80,776.01 14
PY2023 Principal investigator $316,535.63 38
PY2022 Principal investigator $380,511.25 22
PY2021 Principal investigator $21,291.00 6
PY2020 Recipient $900.00 1
PY2020 Principal investigator $221,203.87 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CSL Behring $1,225.00 10/29/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328252
Principal investigator 1 CSL Behring $1,500.00 10/29/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328254
Principal investigator 1 CSL Behring $10,115.34 09/06/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328248
Principal investigator 1 CSL Behring $1,150.00 08/28/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328244
Principal investigator 1 CSL Behring $2,150.00 08/28/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328246
Principal investigator 1 CSL Behring $7,788.50 08/19/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328242
Principal investigator 1 Celgene Corporation $5,000.00 06/06/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Osborn Med Ct
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells No dispute reported 06/30/2026 1120433310
Principal investigator 1 CSL Behring $6,325.00 04/30/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328232
Principal investigator 1 CSL Behring $15,050.00 04/30/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328234
Principal investigator 1 CSL Behring $15,830.32 04/15/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328230
Principal investigator 1 Celgene Corporation $2,477.62 03/12/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Osborn Med Ct
A Study to Compare the Efficacy and Safety ofJCAR017to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas (TRANSFORM) No dispute reported 06/30/2026 1120433340
Principal investigator 1 Celgene Corporation $10,397.73 02/21/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Osborn Med Ct
TRANSFORM 2L TE LBCL BCM-003 - A global randomized multicenter Phase 3 trial of JCAR017 compared to standard of care in adult subjects with high-risk, second-line, transplant-eligible relapsed or refractory aggressive B-cell non-Hodgkin lymphomas (TRANSFO No dispute reported 06/30/2026 1155550657
Principal investigator 1 CSL Behring $445.00 02/02/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328228
Principal investigator 1 CSL Behring $1,321.50 01/10/2024 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft Versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study) No dispute reported 06/30/2026 1142328226